UNI-EN 3:THE INTRODUCTION OF 132,000,000 SHARES IN THE COMPANY TO TRADING ON THE WARSAW STOCK EXCHANGE
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 3 | / | 2011 | | ||||||
| Date of issue: | 2011-11-25 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| THE INTRODUCTION OF 132,000,000 SHARES IN THE COMPANY TO TRADING ON THE WARSAW STOCK EXCHANGE | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| The Board of Directors of SOPHARMA AD (the “Company") announces that in accordance with resolution No. 1432/2011, the management board of the Warsaw Stock Exchange resolved: 1) to introduce as of 28 November 2011 by way of an ordinary procedure all of the shares in the share capital of the Company, i.e. 132,000,000 ordinary bearer shares in the Company, to trading on the main market of the Warsaw Stock Exchange; 2) to list the shares of the Company in the continuous trading system under the abbreviated name “SOPHARMA" and the code “SPH". This material does not constitute an offer to sell, or an invitation or a solicitation of an offer to subscribe for or to buy any securities of the Company. The prospectus in English and its Polish summary constitute the sole and only legally binding documents containing information about the Company, its operations and shares in the context of their admission and introduction to trading on the regulated market operated by the Warsaw Stock Exchange and have been published and are available on the Company’s website (www.sopharma.bg) and on the website of WOOD & Co. Financial Services as (www.wood.com). No offering of the Company’s securities is carried out on the basis of the prospectus in any jurisdiction, including Poland and Bulgaria. This material is not for distribution, directly or indirectly, in or into the United States, or in other countries where the public dissemination of the information contained herein may be restricted or prohibited by law. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | nd | ||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2011-11-25 | Ognian Donev | Chairman of the Board of Directors | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to None PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
